Most Popular Stories
Poll
Featured Jobs
-
Florida Histotechnologist
StaffPointe, LLC - coastal, FL -
New York Ophthalmologist
StaffPointe, LLC - Rochester, NY -
Washington Family Practitioner
StaffPointe, LLC - near Seattle , WA -
New York Pulmonologist/CC
StaffPointe, LLC - east, NY -
Michigan RN Mgr Patient Care Svcs
StaffPointe, LLC - Battle Creek , MI
Events
- World Health Care Congress
April 14-16, 2009 — Washington, DC - World Healthcare Innovation & Technology Congress WHIT v.4.0
Dec 8-10 — Washington, DC
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies
Popular Topics
CMS mulls reimbursement cuts for cardiac devices
CMS is considering reducing Medicare reimbursements for implantable heart devices, a change that could be a painful hit for specialty hospitals and device makers, if it does in fact go through. The cuts would impact some of the most lucrative heart device categories on the market, including pacemakers, defibrillators and stents. CMS officials say the changes are necessary to eliminate loopholes that specialty hospitals had been exploiting. The agency is weighing reducing payments for stents by more than 30 percent and defibrillators by around 20 percent. Under the proposed rules, by 2008 cardiac hospitals will suffer an 11.7 percent reduction in payments; orthopedic centers, a 9.4 percent decline; and surgical hospitals, a 7.2 percent drop.
- see this article from the Wall Street Journal
Related Stories
- FDA to tighten medical device safety regs
- Medical device monitoring network runs short on funding
- Study: Primary care MDs don't know when to recommend defibrillators
- FDA says CT scans can make medical devices malfunction
- New CMS payment system not as bad as expected
- Boston Scientific announces recall, shares drop
- FDA to monitor heart device safety
- Panel chastises Guidant over recall
- Questions raised on Guidant recall
- Guidant bid deadline approaches for J&J
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceSarbox | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceBiotech | FierceBioResearcher | FiercePharma | FierceVaccines | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2008 FierceMarkets, Inc. All rights reserved. |
![]() |





